We observed an upregulation of the organic cation transporter SLC22A16 following exposure with cold plasma-derived oxidants in a subset of cancer cell lines, which was inhibited by antioxidant catalase and Ca2+ channel inhibitor BTP2. The gene discussed is SLC22A16; the disease is cancer.